🇺🇸 FDA
Patent

US 7049291

Isolation and method of using tissue growth-inducing Frzb protein

expired A61KA61K35/12A61K38/1709

Quick answer

US patent 7049291 (Isolation and method of using tissue growth-inducing Frzb protein) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 23 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K35/12, A61K38/1709